Therapeutic Asset Ratings
19,639 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pirfenidone
Pulmonary Fibrosis
Boehringer Ingelheim
P2
BB
(66)
Ponatinib
Chronic Myeloid Leukemia
Otsuka Beijing Research Institute
P2
BB
(66)
PREDNISONE TABLETS
Intraocular Lymphoma
Peking Union Medical College Hospital
P2
BB
(66)
PREDNISONE TABLETS
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center
P2
BB
(66)
Raltitrexed
Raltitrexed
Meng Qiu
P2
BB
(66)
Romidepsin
Hematologic Diseases
Baptist Health South Florida
P2
BB
(66)
Romidepsin
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota
P2
BB
(66)
Saroglitazar
Metabolic Dysfunction-Associated Steatohepatitis
Zydus Therapeutics Inc.
P2
BB
(66)
TACROLIMUS
Hematologic Disorder
University of Michigan Rogel Cancer Center
P2
BB
(66)
TACROLIMUS
Prolymphocytic Leukemia
Center for International Blood and Marrow Transplant Research
P2
BB
(66)
Tazemetostat
Rhabdoid Tumor
Epizyme, Inc.
P2
BB
(66)
Tazemetostat
Rhabdoid Tumor
Epizyme, Inc.
P2
BB
(66)
Tislelizumab
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P2
BB
(66)
Tislelizumab
Acute Myeloid Leukemia With Positive Minimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China
P2
BB
(66)
Trifluridine
Metastatic Colorectal Carcinoma
Mayo Clinic
P2
BB
(66)
Veliparib
Ovarian Carcinoma
National Cancer Institute (NCI)
P2
BB
(66)
Veliparib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P2
BB
(66)
Venetoclax
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer Center
P2
BB
(66)
Venetoclax
Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(66)
(+)-VINCRISTINE
Accelerated Phase Chronic Myelogenous Leukemia
University of Michigan Rogel Cancer Center
P2
BB
(66)
(+)-VINCRISTINE
Indolent B-Cell Non-Hodgkin Lymphoma
Fate Therapeutics
P2
BB
(66)
(+)-VINCRISTINE
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center
P2
BB
(66)
(+)-VINCRISTINE
Myelodysplastic Syndrome
Andrew E. Place, MD
P2
BB
(66)
(+)-VINCRISTINE
Ovarian Carcinosarcoma
National Cancer Institute (NCI)
P2
BB
(66)
VINCRISTINE SULFATE
B-cell Lymphoid Malignancies
Curis, Inc.
P2
BB
(66)
Showing 701 to 725 of 19,639 assets
Previous
Page 29 of 786
Next